{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T16:26:56Z","timestamp":1794587216809,"version":"4.9.1"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"25","license":[{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,6,19]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Fecal occult blood test (FOBT) is widely used in colorectal cancer (CRC) screening; however, its ability to predict clinically significant pathology may vary across patient populations. This study aimed to evaluate colonoscopy outcomes in FOBT-positive patients and to identify clinical factors associated with clinically significant colonoscopic findings. This retrospective single-center cohort study included 216 adult patients with positive FOBT results who underwent colonoscopy between 2018 and 2024. Demographic characteristics, hemoglobin levels, FOBT methods, colonoscopic findings, and histopathological results were analyzed. Clinically significant pathology was defined as the presence of adenoma, advanced adenoma, CRC, or inflammatory lesions. Multivariable logistic regression analysis was performed to identify factors associated with clinically significant pathology, and receiver operating characteristic analysis was used to evaluate discriminative performance. Clinically significant pathology was detected in 57.4% of patients. The most frequent findings were adenomas (28.7%), advanced adenomas (14.8%), and CRC (8.3%). Older age (\u226560 years), male sex, and anemia were significantly associated with clinically significant findings. Among these variables, anemia showed the strongest association with significant pathology. Receiver operating characteristic analysis demonstrated moderate discriminative ability for individual variables, whereas a combined model incorporating age, sex, and anemia achieved the highest performance (area under the curve\u2005=\u20050.81). FOBT positivity was associated with a high rate of clinically significant colonoscopic findings. Older age, male sex, and anemia may help identify higher-risk patients; however, these factors should not be used to exclude any FOBT-positive patient from colonoscopy. Prospective multicenter studies are needed to validate these findings.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000049414","type":"journal-article","created":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T06:00:52Z","timestamp":1782108052000},"page":"e49414","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Colonoscopy outcomes and clinical factors associated with significant findings in patients with positive fecal occult blood tests: A retrospective cohort study"],"prefix":"10.1097","volume":"105","author":[{"given":"Mehmet Emin","family":"G\u00f6n\u00fcll\u00fc","sequence":"first","affiliation":[{"name":"Department of General Surgery, Bilecik \u015eeyh Edebali University Faculty of Medicine, Bilecik, T\u00fcrkiye"},{"name":"Department of General Surgery, Duzce University Faculty of Medicine, Duzce, T\u00fcrkiye."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9418-7288","authenticated-orcid":false,"given":"Mehmet Fuat","family":"\u00c7etin","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Duzce University Faculty of Medicine, Duzce, T\u00fcrkiye."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erman","family":"Yekenkurul","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Duzce University Faculty of Medicine, Duzce, T\u00fcrkiye."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatih","family":"G\u00fcrsoy","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Duzce University Faculty of Medicine, Duzce, T\u00fcrkiye."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20261113","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1136\/gutjnl-2022-327736","article-title":"Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN.","volume":"72","author":"Morgan","year":"2023","journal-title":"Gut"},{"key":"R2-20261113","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"R3-20261113","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.3748\/wjg.v30.i20.2726","article-title":"Colorectal cancer screening: the value of early detection and modern challenges.","volume":"30","author":"Li","year":"2024","journal-title":"World J Gastroenterol"},{"key":"R4-20261113","first-page":"89","article-title":"Epidemiology of colorectal cancer: incidence, mortality, survival, and risk factors.","volume":"14","author":"Rawla","year":"2019","journal-title":"Przeglad Gastroenterol"},{"key":"R5-20261113","first-page":"95","article-title":"How effective is a fecal occult blood test to detect malignancy?","volume":"10","author":"\u015eahin","year":"2022","journal-title":"Namik Kemal Med J"},{"key":"R6-20261113","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/1751-2980.12712","article-title":"Fecal occult blood test in colorectal cancer screening.","volume":"20","author":"Li","year":"2019","journal-title":"J Dig Dis"},{"key":"R7-20261113","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5604\/01.3001.0015.9661","article-title":"Fecal occult blood test, is it still worth for colorectal cancer screening?","volume":"95","author":"Esmer","year":"2022","journal-title":"Polski Przeglad Chirurgiczny"},{"key":"R8-20261113","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/1751-2980.12711","article-title":"Quantitative immunochemical fecal occult blood test for neoplasia in colon cancer screening.","volume":"20","author":"Yuan","year":"2019","journal-title":"J Dig Dis"},{"key":"R9-20261113","doi-asserted-by":"crossref","first-page":"5014","DOI":"10.3390\/ijerph16245014","article-title":"Temporal trends in fecal occult blood test: associated factors (2009-2017).","volume":"16","author":"Cobo-Cuenca","year":"2019","journal-title":"Int J Environ Res Public Health"},{"key":"R10-20261113","doi-asserted-by":"crossref","first-page":"5086","DOI":"10.3748\/wjg.v23.i28.5086","article-title":"Colorectal cancer screening: an updated review of the available options.","volume":"23","author":"Issa","year":"2017","journal-title":"World J Gastroenterol"},{"key":"R11-20261113","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4274\/tjcd.48403","article-title":"Colonoscopy findings in patients who have positive fecal occult blood test for colorectal cancer screening.","volume":"28","author":"Mayir","year":"2018","journal-title":"Turk J Colorectal Dis"},{"key":"R12-20261113","doi-asserted-by":"crossref","first-page":"59","DOI":"10.47717\/turkjsurg.2024.6352","article-title":"Colorectal cancer screening; colonoscopy and biopsy results in people undergoing colonoscopy due to positive fecal occult blood test.","volume":"40","author":"Y\u00fccel","year":"2024","journal-title":"Tur J Surg"},{"key":"R13-20261113","doi-asserted-by":"crossref","first-page":"719","DOI":"10.5946\/ce.2019.149","article-title":"Positive fecal occult blood test is a predictive factor for gastrointestinal bleeding after capsule endoscopy in patients with unexplained iron deficiency anemia: a Korean multicenter CAPENTRY Study.","volume":"53","author":"Chang","year":"2020","journal-title":"Clin Endoscopy"},{"key":"R14-20261113","first-page":"e88524","article-title":"Assessment of fecal occult blood testing in acute hospital settings: perspectives of internal medicine residents in a multicenter study.","volume":"17","author":"Challa","year":"2025","journal-title":"Cureus"},{"key":"R15-20261113","doi-asserted-by":"crossref","first-page":"819","DOI":"10.14744\/nci.2022.94103","article-title":"Recognition and participation of colorectal cancer screening in Turkiye: a systematic review and meta-analysis study.","volume":"10","author":"Aydogan Gedik","year":"2023","journal-title":"Northern Clin Istanbul"},{"key":"R16-20261113","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.1002\/ijc.21774","article-title":"New immunochemical fecal occult blood test with two-consecutive stool sample testing is a cost-effective approach for colon cancer screening: results of a prospective multicenter study in Chinese patients.","volume":"118","author":"Li","year":"2006","journal-title":"Int J Cancer"},{"key":"R17-20261113","first-page":"747","article-title":"Colonoscopy: preparation and potential complications.","volume":"12","author":"Latos","year":"2022","journal-title":"Diagnostics (Basel, Switzerland)"},{"key":"R18-20261113","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1016\/j.cgh.2023.03.036","article-title":"Blood test increases colorectal cancer screening in persons who declined colonoscopy and fecal immunochemical test: a randomized controlled trial.","volume":"21","author":"Liang","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"9 Suppl 1","key":"R19-20261113","doi-asserted-by":"crossref","first-page":"S91","DOI":"10.1097\/MLR.0b013e31817946c8","article-title":"Improvement in the diagnostic evaluation of a positive fecal occult blood test in an integrated health care organization.","volume":"46","author":"Miglioretti","year":"2008","journal-title":"Med Care"},{"key":"R20-20261113","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1055\/s-0044-100721","article-title":"Colon capsule versus computed tomography colonography for colorectal cancer screening in patients with positive fecal occult blood test who refuse colonoscopy: a randomized trial.","volume":"50","author":"Pioche","year":"2018","journal-title":"Endoscopy"},{"key":"R21-20261113","first-page":"366","article-title":"The effectiveness of FOBT vs. FIT: a meta-analysis on colorectal cancer screening test.","volume":"30","author":"Mousavinezhad","year":"2016","journal-title":"Med J Islamic Republic Iran"},{"key":"R22-20261113","doi-asserted-by":"crossref","first-page":"5539","DOI":"10.3390\/jcm14155539","article-title":"Sex differences in colorectal cancer: epidemiology, risk factors, and clinical outcomes.","volume":"14","author":"Tsokkou","year":"2025","journal-title":"J Clin Med"},{"key":"R23-20261113","doi-asserted-by":"crossref","first-page":"163","DOI":"10.21873\/cdp.10196","article-title":"Iron deficiency anemia in colorectal cancer patients: is preoperative intravenous iron infusion indicated? A narrative review of the literature.","volume":"3","author":"Chardalias","year":"2023","journal-title":"Cancer Diagnosis Prognosis"},{"key":"R24-20261113","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1155\/2013\/612314","article-title":"Relationship between the number of positive fecal occult blood tests and the diagnostic yield of colonoscopy.","volume":"27","author":"Muinuddin","year":"2013","journal-title":"Can J Gastroenterol"},{"key":"R25-20261113","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s003840000255","article-title":"Colorectal cancer in iron deficiency anemia with a positive result on immunochemical fecal occult blood.","volume":"15","author":"Nakama","year":"2000","journal-title":"Int J Colorectal Dis"},{"key":"R26-20261113","doi-asserted-by":"crossref","first-page":"e001876","DOI":"10.1136\/bmjgast-2025-001876","article-title":"Faecal occult blood testing: a review of its use and common misutilisation.","volume":"12","author":"M\u00e9ndez","year":"2025","journal-title":"BMJ Open Gastroenterol"},{"key":"R27-20261113","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1053\/j.gastro.2017.05.004","article-title":"Interval colorectal cancer incidence among subjects undergoing multiple rounds of fecal immunochemical testing.","volume":"153","author":"van der Vlugt","year":"2017","journal-title":"Gastroenterology"},{"key":"R28-20261113","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1136\/gut.2006.101428","article-title":"Comparison of a guaiac based and an immunochemical faecal occult blood test in screening for colorectal cancer in a general average risk population.","volume":"56","author":"Guittet","year":"2007","journal-title":"Gut"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000049414","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T16:01:25Z","timestamp":1794585685000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000049414"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,19]]},"references-count":28,"journal-issue":{"issue":"25","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000049414","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,19]]},"assertion":[{"value":"2025-12-23","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-05","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}